CRANBURY, N.J., Aug. 1, 2012 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases, today announced a conference call and live audio webcast on Tuesday, August 7, 2012 at 5:00 p.m. ET to discuss financial results for the second quarter ended June 30, 2012.
